BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7979624)

  • 1. Canine leishmaniasis: clinical, parasitological and entomological follow-up after chemotherapy.
    Alvar J; Molina R; San Andrés M; Tesouro M; Nieto J; Vitutia M; González F; San Andrés MD; Boggio J; Rodriguez F
    Ann Trop Med Parasitol; 1994 Aug; 88(4):371-8. PubMed ID: 7979624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative efficacy of meglumine antimoniate and aminosidine sulphate, alone or in combination, in canine leishmaniasis.
    Oliva G; Gradoni L; Cortese L; Orsini S; Ciaramella P; Scalone A; de Luna R; Persechino A
    Ann Trop Med Parasitol; 1998 Mar; 92(2):165-71. PubMed ID: 9625912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment.
    Gradoni L; Maroli M; Gramiccia M; Mancianti F
    Med Vet Entomol; 1987 Oct; 1(4):339-42. PubMed ID: 2979550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased sensitivity to meglumine antimoniate (Glucantime) of Leishmania infantum isolated from dogs after several courses of drug treatment.
    Gramiccia M; Gradoni L; Orsini S
    Ann Trop Med Parasitol; 1992 Dec; 86(6):613-20. PubMed ID: 1304703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment.
    Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M
    Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential of Artesunate in the treatment of visceral leishmaniasis in dogs naturally infected by Leishmania infantum: Efficacy evidence from a randomized field trial.
    Medkour H; Bitam I; Laidoudi Y; Lafri I; Lounas A; Hamidat HK; Mekroud A; Varloud M; Davoust B; Mediannikov O
    PLoS Negl Trop Dis; 2020 Dec; 14(12):e0008947. PubMed ID: 33338041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First report of the use of meglumine antimoniate for treatment of canine leishmaniasis in a pregnant dog.
    Spada E; Proverbio D; Groppetti D; Perego R; Grieco V; Ferro E
    J Am Anim Hosp Assoc; 2011; 47(1):67-71. PubMed ID: 21164165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate.
    Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M
    Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evolution of serum albumin/globulin ratio after antimonial therapy in canine leishmaniasis.
    Amusategui I; Sainz A; Tesouro MA
    Ann N Y Acad Sci; 1998 Jun; 849():447-9. PubMed ID: 9668510
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.
    Miret J; Nascimento E; Sampaio W; França JC; Fujiwara RT; Vale A; Dias ES; Vieira E; da Costa RT; Mayrink W; Campos Neto A; Reed S
    Vaccine; 2008 Mar; 26(12):1585-94. PubMed ID: 18328956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on canine leishmaniasis control. 1. Evolution of infection of different clinical forms of canine leishmaniasis following antimonial treatment.
    Mancianti F; Gramiccia M; Gradoni L; Pieri S
    Trans R Soc Trop Med Hyg; 1988; 82(4):566-7. PubMed ID: 3076714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced tissue parasitic load and infectivity to sand flies in dogs naturally infected by Leishmania (Leishmania) chagasi following treatment with a liposome formulation of meglumine antimoniate.
    Ribeiro RR; Moura EP; Pimentel VM; Sampaio WM; Silva SM; Schettini DA; Alves CF; Melo FA; Tafuri WL; Demicheli C; Melo MN; Frézard F; Michalick MS
    Antimicrob Agents Chemother; 2008 Jul; 52(7):2564-72. PubMed ID: 18458133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and parasitological evaluation of dogs naturally infected by Leishmania (Leishmania) chagasi submitted to treatment with meglumine antimoniate.
    Ikeda-Garcia FA; Lopes RS; Marques FJ; de Lima VM; Morinishi CK; Bonello FL; Zanette MF; Perri SH; Feitosa MM
    Vet Parasitol; 2007 Feb; 143(3-4):254-9. PubMed ID: 16996214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of Western blotting in the clinical follow-up of canine leishmaniasis.
    Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM
    J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic Efficacy of a Mixed Formulation of Conventional and PEGylated Liposomes Containing Meglumine Antimoniate, Combined with Allopurinol, in Dogs Naturally Infected with Leishmania infantum.
    Dos Santos CCP; Ramos GS; De Paula RC; Faria KF; Moreira POL; Pereira RA; Melo MN; Tafuri WL; Demicheli C; Ribeiro RR; Azevedo EG; Do Monte-Neto R; Da Silva SM; Frézard F
    Antimicrob Agents Chemother; 2020 Jun; 64(7):. PubMed ID: 32284386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol.
    Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL
    Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased antimony uptake and overexpression of genes of thiol metabolism are associated with drug resistance in a canine isolate of Leishmania infantum.
    Gómez Pérez V; García-Hernandez R; Corpas-López V; Tomás AM; Martín-Sanchez J; Castanys S; Gamarro F
    Int J Parasitol Drugs Drug Resist; 2016 Aug; 6(2):133-9. PubMed ID: 27317865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum.
    Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M
    Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine visceral leishmaniasis: comparison of in vitro leishmanicidal activity of marbofloxacin, meglumine antimoniate and sodium stibogluconate.
    Vouldoukis I; Rougier S; Dugas B; Pino P; Mazier D; Woehrlé F
    Vet Parasitol; 2006 Jan; 135(2):137-46. PubMed ID: 16242844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments.
    Miró G; Gálvez R; Fraile C; Descalzo MA; Molina R
    Parasit Vectors; 2011 Apr; 4():52. PubMed ID: 21489241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.